2026 Q2 Portfolio Activity
In 2026 Q2, DEERFIELD MANAGEMENT COMPANY, L.P. maintained a portfolio of 95 distinct positions. The most significant new addition was MINERALYS THERAPEUTICS INC, now representing 1.11% of the total fund value. They heavily accumulated shares in BROOKDALE SR LIVING INC, increasing the position by 55697.3%. The fund also reduced its exposure to BROOKDALE SR LIVING INC by 95.8%.
Position History
hover any row below to update
Loading…
Total Positions
95
Quarter
2026 Q2
Top Holding
NUVL (22.2%)
Top 10 Concentration
53.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 95
DEERFIELD MANAGEMENT COMPANY, L.P. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NUVL
NUVALENT INC
|
Healthcare | 22.22% | 20.85% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
17,248,450 | $2,130,183,575 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
BROOKDALE SR LI...
|
|
Bond/Debt | 6.11% | 5.96% |
#2
Prev: #2
|
4.9 |
—
|
no change | no change |
P
S
|
306,885,000 | $585,704,753 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 4.67% | 2.64% |
#3
4
Prev: #7
|
3.4 |
—
|
95,000 | 4.1% |
P
S
|
2,392,000 | $447,973,760 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 3.36% | 3.66% |
#4
Prev: #4
|
2.8 |
—
|
no change | no change |
P
S
|
963,351 | $322,520,281 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VTRS
VIATRIS INC
|
Healthcare | 3.35% | 3.22% |
#5
Prev: #5
|
2.8 |
—
|
no change | no change |
P
S
|
20,206,170 | $320,873,980 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 3.28% | 2.29% |
#6
5
Prev: #11
|
1.8 |
—
|
-1,016,091 | -17.2% |
P
S
|
4,901,000 | $314,595,190 | 2005 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
REVOLUTION MEDI...
|
|
Bond/Debt | 2.63% | — |
#7
Prev: #—
|
4.6 |
—
|
200,000,000 | — |
NEW
|
200,000,000 | $251,681,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.58% | 3.20% |
#8
2
Prev: #6
|
2.0 |
—
|
no change | no change |
P
S
|
457,000 | $247,616,310 | 2007 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ARROWHEAD PHARM...
|
|
Bond/Debt | 2.51% | 2.44% |
#9
Prev: #9
|
2.0 |
—
|
no change | no change |
P
S
|
200,000,000 | $240,537,600 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 2.45% | 1.64% |
#10
8
Prev: #18
|
3.0 |
—
|
450,000 | 5.9% |
P
S
|
8,137,638 | $235,014,985 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.02% | 4.11% |
#11
8
Prev: #3
|
0.8 |
—
|
-4,037,799 | -44.6% |
P
S
|
5,006,104 | $193,736,225 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 1.97% | 0.78% |
#12
27
Prev: #39
|
3.8 |
—
|
4,403,000 | 178.8% |
P
S
|
6,865,000 | $188,581,550 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 1.95% | 1.88% |
#13
Prev: #13
|
1.8 |
—
|
no change | no change |
P
S
|
11,637,032 | $187,239,845 | 2007 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.75% | 1.77% |
#14
Prev: #14
|
2.7 |
—
|
194,300 | 5.2% |
P
S
|
3,916,400 | $168,052,724 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.64% | 1.75% |
#15
Prev: #15
|
1.7 |
—
|
no change | no change |
P
S
|
1,979,669 | $156,967,955 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 1.58% | 2.31% |
#16
6
Prev: #10
|
1.1 |
—
|
-262,986 | -15.3% |
P
S
|
1,451,014 | $151,805,085 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.57% | 1.69% |
#17
1
Prev: #16
|
1.1 |
—
|
58,403 | 0.4% |
P
S
|
15,096,403 | $150,964,030 | 2005 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 1.51% | 1.61% |
#18
2
Prev: #20
|
1.6 |
—
|
no change | no change |
P
S
|
4,264,789 | $144,533,699 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 1.39% | 1.25% |
#19
2
Prev: #21
|
1.6 |
—
|
no change | no change |
P
S
|
4,520,000 | $133,475,600 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.37% | 1.02% |
#20
9
Prev: #29
|
1.0 |
—
|
43,798 | 1.1% |
P
S
|
4,190,611 | $130,998,500 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AHCO
ADAPTHEALTH COR...
|
Healthcare | 1.25% | 1.61% |
#21
2
Prev: #19
|
1.5 |
—
|
no change | no change |
P
S
|
11,477,730 | $119,597,947 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.22% | 1.04% |
#22
5
Prev: #27
|
2.5 |
—
|
250,000 | 8.0% |
P
S
|
3,376,042 | $116,743,532 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CELCUITY INC
|
|
Bond/Debt | 1.19% | — |
#23
Prev: #—
|
4.0 |
—
|
100,000,000 | — |
NEW
|
100,000,000 | $113,779,900 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.18% | 1.16% |
#24
2
Prev: #22
|
1.0 |
—
|
-184,242 | -11.7% |
P
S
|
1,389,055 | $113,221,873 | 2013 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.14% | 1.01% |
#25
6
Prev: #31
|
2.5 |
—
|
105,500 | 10.3% |
P
S
|
1,125,313 | $109,695,511 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 1.13% | 1.89% |
#26
14
Prev: #12
|
1.5 |
—
|
no change | no change |
P
S
|
35,606,974 | $108,601,271 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.11% | — |
#27
Prev: #—
|
3.9 |
—
|
3,958,000 | — |
NEW
|
3,958,000 | $106,786,840 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ALIGNMENT HEALT...
|
|
Bond/Debt | 1.08% | 1.01% |
#28
2
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
61,000,000 | $103,829,930 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.06% | 0.60% |
#29
16
Prev: #45
|
3.4 |
—
|
1,184,495 | 77.4% |
P
S
|
2,714,503 | $101,169,527 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.02% | 1.11% |
#30
5
Prev: #25
|
1.4 |
—
|
no change | no change |
P
S
|
1,615,696 | $97,523,411 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
IONIS PHARMACEU...
|
|
Bond/Debt | 0.97% | 1.07% |
#31
5
Prev: #26
|
1.4 |
—
|
no change | no change |
P
S
|
60,000,000 | $93,104,400 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
SVRA
SAVARA INC
|
Healthcare | 0.87% | 0.87% |
#32
3
Prev: #35
|
1.3 |
—
|
no change | no change |
P
S
|
13,569,000 | $83,585,040 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 0.87% | 0.74% |
#33
8
Prev: #41
|
0.8 |
—
|
-75,000 | -9.1% |
P
S
|
752,999 | $83,537,709 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.86% | 1.04% |
#34
6
Prev: #28
|
1.3 |
—
|
no change | no change |
P
S
|
3,779,900 | $82,628,614 | 2017 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ZENAS BIOPHARMA...
|
|
Bond/Debt | 0.84% | 0.79% |
#35
1
Prev: #36
|
0.8 |
—
|
2,200,000 | 3.4% |
P
S
|
67,200,000 | $80,316,096 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.80% | 0.57% |
#36
11
Prev: #47
|
3.3 |
—
|
481,280 | 56.5% |
P
S
|
1,332,836 | $76,264,876 | 2001 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.76% | 1.01% |
#37
5
Prev: #32
|
1.3 |
—
|
no change | no change |
P
S
|
3,040,000 | $73,203,200 | 2000 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 0.71% | 1.11% |
#38
14
Prev: #24
|
0.3 |
—
|
-1,448,895 | -46.8% |
P
S
|
1,648,895 | $67,654,162 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 0.69% | 0.74% |
#39
1
Prev: #40
|
1.3 |
—
|
no change | no change |
P
S
|
226,070 | $66,376,413 | 2003 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.63% | 0.71% |
#40
2
Prev: #42
|
1.3 |
—
|
no change | no change |
P
S
|
7,503,812 | $60,105,534 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.62% | 0.70% |
#41
2
Prev: #43
|
1.2 |
—
|
no change | no change |
P
S
|
1,823,500 | $59,664,920 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.61% | 0.44% |
#42
13
Prev: #55
|
2.7 |
—
|
318,007 | 41.4% |
P
S
|
1,086,000 | $58,285,620 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVST
ENVISTA HOLDING...
|
Healthcare | 0.61% | 0.66% |
#43
1
Prev: #44
|
1.2 |
—
|
no change | no change |
P
S
|
2,210,100 | $58,236,135 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 0.60% | 1.64% |
#44
27
Prev: #17
|
0.2 |
—
|
-1,406,376 | -52.0% |
P
S
|
1,296,862 | $57,853,014 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CDNA
CAREDX INC
|
Healthcare | 0.59% | 0.45% |
#45
9
Prev: #54
|
0.7 |
—
|
-193,382 | -8.8% |
P
S
|
1,997,618 | $56,932,113 | 2014 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.59% | — |
#46
Prev: #—
|
3.7 |
—
|
1,315,000 | — |
NEW
|
1,315,000 | $56,124,200 | 1999 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 0.57% | 0.57% |
#47
1
Prev: #46
|
2.2 |
—
|
53,186 | 17.5% |
P
S
|
357,199 | $55,003,288 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PBLS
PARABILIS MEDIC...
|
Healthcare | 0.54% | — |
#48
Prev: #—
|
3.7 |
—
|
1,880,704 | — |
NEW
|
1,880,704 | $51,474,868 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CERT
CERTARA INC
|
Healthcare | 0.51% | 0.53% |
#49
Prev: #49
|
0.7 |
—
|
-295,677 | -3.8% |
P
S
|
7,512,928 | $49,209,678 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.50% | 0.50% |
#50
1
Prev: #51
|
1.2 |
—
|
no change | no change |
P
S
|
657,000 | $48,052,980 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 95 holdings